Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Sequential Analysis of Donor-Specific Antibodies and Pathological Findings Using Intravenous Immunoglobulin in a Highly Sensitized Rat Kidney Transplant Model.
Y. Sawada,¹ K. Omoto,² N. Kohei,⁴ K. Kawanishi,³ M. Okumi,² H. Ishida,² T. Kazunari.²
¹Urology, Fukushima Rosai Hospital, Iwaki, Japan; ²Urology, Tokyo Women's Medical University, Tokyo, Japan; ³Pathology, Tokyo Women's Medical University, Tokyo, Japan; ⁴Urology, Shizuoka General Hospital, Shizuoka, Japan.
Intravenous immunoglobulin (IVIG) has evolved widespread use for treatment of acute antibody-mediated rejection (AAMR) and desensitization in highly HLA-sensitized patients. However, sequential change of the…
2016 American Transplant Congress
Transient Hepatitis B Core Positivity After Administration of IVIG for Desensitization (DES).
A. Nejad, A. Vo, J. Choi, S. Jordan.
Kidney Transplant, Cedars-Sinai Medical Center, LA, CA.
INTRODUCTION: IVIG has become an essential tool in the treatment of sensitized patients prior to solid organ transplantation and is routinely used to treat viral…
2016 American Transplant Congress
Age Gap Analysis Between Live Donor and Recipients in Kidney Transplantation: Opportunities to Improve Voluntary Exchange Programs and Kidney Paired Donation.
J. Rodriguez,¹ A. Patel,² M. Goggins.²
¹Internal Medicine, Henry Ford Hospital, Detroit, MI; ²Transplant Institute, Henry Ford Hospital, Detroit, MI; ³Transplant Institute, Henry Ford Hospital, Detroit, MI.
Graft survival(GS) perception is that, with a smaller age gap between the donor(D) and recipient(R), better the outcome. It is unclear if there is an…
2016 American Transplant Congress
Transcriptome Profiles in Peripheral Blood of Kidney Graft Recipients.
J.-W. Seo,¹ H. Moon,¹ Y.-G. Kim,¹ K.-H. Jeong,¹ S.-J. Ihm,² J.-Y. Moon,¹ S.-H. Lee.¹
¹Division of Nephrology, Department of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea; ²Department of Pathology, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
The discovery of sensitive noninvasive diagnosis and the development of immune management in the renal allograft recipients are required for long-term graft survival. Although the…
2016 American Transplant Congress
A 30% Decrease in Post-kidney Transplant Estimated Glomerular Filtration Rate (eGFR) from 6 Mo-2 Y Is a Surrogate for 5 Y eGFR: Results from Clinical Trials in Organ Transplantation-(CTOT)-17.
G. Faddoul,¹ G. Nadkarni,¹ D. Hricik,² P. Heeger,¹ CTOT17 Investigators.
¹Medicine and Recanati Miller Transplant Institute, Icahn School of Medicine, NY, NY; ²Medicine, Case Medical Center, Cleveland, OH.
Predicting long-term kidney allograft outcomes using early clinical/biomarker data could guide individualized therapy. Emerging evidence in progressive native kidney disease indicates >30% decrease in eGFR…
2016 American Transplant Congress
Should Obese Patients Undergo Renal Transplantation? A Retrospective Analysis to Assess Whether Body Mass Index Can Affect Transplant Outcome.
A. Mehta,¹ A. Marriott,¹ A. Ghazanfar.²
¹St. George's, University of London, London, United Kingdom; ²Renal Transplant Unit, St. George's Hospital, London, United Kingdom.
This study aims to analyze our renal transplant recipient population in terms of perioperative complications (90 day) and graft survival (3 years) in relation to…
2016 American Transplant Congress
Urinary Markers of Proximal Tubular Dysfunction in Kidney Transplant as Predictors for CKD.
P. Garcia, V. Garcia-Nieto, J. Navarro, E. Martin, A. Rivero, A. Jarque, J. Gonzalez-Posadas, M. Macia.
Nephrology, Universitary NTRA.SRA.Candelaria Hospital, SC Tenerife, Spain.
AIMS:Analyze urinary markers of proximal tubular dysfunction (PTD)(b2 microglobulin (b2m),N-acetyl-glucosaminidase (NAG) and Clara Cell Protein (CC16)) in kidney transplant (KT) patients, compared with a healthy…
2016 American Transplant Congress
The Impact of Non-Adherence on Disparities in African-American Kidney Transplant Recipients.
D. Taber, A. Chokkalingam, A. Posadas, R. Browning, N. Salazar, M. Kamel, R. Pullalarevu, B. Kadri, T. Srinivas, K. Chavin, P. Baliga.
MUSC, Charleston, SC.
Background: Non-adherence is considered to a be a strong risk factor for graft loss in kidney transplant recipients, with conflicting evidence of its impact on…
2016 American Transplant Congress
Rapid Discontinuation of Prednisone (RDP) in Kidney Transplant (KTx) Recipients: 15-Year Outcomes.
O. Serrano,¹ R. Kandaswamy,¹ K. Gillingham,¹ W. Payne,¹ T. Dunn,¹ S. Chinnakotla,¹ E. Finger,¹ H. Ibrahim,² A. Kukla,² R. Spong,² N. Issa,² T. Pruett,¹ A. Matas.¹
¹Surgery, University of Minnesota, Minneapolis, MN; ²Medicine, University of Minnesota, Minneapolis, MN.
PURPOSE: RDP after KTx is associated with increased early rejection; no decrease in medium‐term patient (PS) or graft survival (GS); and significantly decreased prednisone‐related side…
2016 American Transplant Congress
Benefit of Mycophenolate Mofetile Addition to Very Low Exposure Everolimus and Calcineurine Inhibitor Based Immunosuppression in De Novo Kidney Transplantation with 2 Years Follow-Up.
Y. Watarai,¹ M. Okada,¹ K. Futamura,¹ T. Nagai,¹ T. Yamamoto,¹ M. Tsujita,¹ T. Hiramitsu,¹ N. Goto,¹ S. Narumi,¹ T. Kobayashi.²
¹Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan; ²Kidney Transplant Surgery, Aichi Medical University, Nagoya, Aichi, Japan.
Purpose: Prospective randomized study of MMF addition to everolimus (EVR) based immunosuppression in order to further reduction of EVR and CNI was evaluated in clinical…